Inhibikase Therapeutics, Inc. Employee Directory

Pharmaceutical ManufacturingDelaware, United States11-50 Employees

Inhibikase Therapeutics, Inc. (Nasdaq: IKT) is a clinical-stage pharmaceutical company developing therapeutics to modify the course of cardiopulmonary diseases namely, Pulmonary Arterial Hypertension (“PAH”), that arise from aberrant signaling through the Abelson Tyrosine Kinase, and type III receptor tyrosine kinases including platelet derived growth factor receptors and c-KIT. Our lead product candidate is IKT-001, a prodrug of imatinib mesylate, for PAH which is an orphan indication. PAH is a progressive, life-threatening disease characterized by pulmonary vascular remodeling and elevated pulmonary vascular resistance that affects approximately 50,000 Americans. 

Inhibikase is headquartered in Wilmington, DE with additional offices in Boston, Massachusetts.

Find Inhibikase Therapeutics, Inc. employees' phone numbers or email addresses

Inhibikase Therapeutics, Inc. Global Highlights

North America
31

United States Of America
30
Canada
1

Europe
1

Netherlands
1

South America
1

Brazil
1

Inhibikase Therapeutics, Inc.'s Leadership

J. J. K.
Chief Human Resources Officer
Mobile Phone
Email
J. F.
Chief Financial Officer
Mobile Phone
Email
K. W.
Vice President Finance
Mobile Phone
Email
C. M.
Vice President Of Clinical Operations
Mobile Phone
Email
R. A.
President
Mobile Phone
Email
S. S.
Head Of Program Leadership
Mobile Phone
Email
A. M.
Chairman
Mobile Phone
Email
J. A.
Owner
Mobile Phone
Email

Inhibikase Therapeutics, Inc. Employee Metrics

100%

50%

0%

2026

2025

Business
Entrepreneurship
Human Resources
Accounting
Biotechnology
Other
Community & Social Services

Contact profiles from Inhibikase Therapeutics, Inc.

Name

Title

Contact Info

Location

Last Update

A. M.
Chairman
Mobile Phone
Email
United StatesUtah
Mar 24, 2026
J. A.
Owner
Mobile Phone
Email
Oct 17, 2024
J. J. K.
Chief Human Resources Officer
Mobile Phone
Email
United States
Mar 05, 2026
J. F.
Chief Financial Officer
Mobile Phone
Email
Oct 24, 2024
R. A.
President
Mobile Phone
Email
Oct 23, 2024
M. S.
Vice President, Cmc Development
Mobile Phone
Email
United StatesNorth Carolina
Mar 24, 2026
A. W.
Vice President, Head Of Clinical Development
Mobile Phone
Email
United States
Dec 18, 2025
K. W.
Vice President Finance
Mobile Phone
Email
United StatesMassachusetts
Feb 11, 2026
M. A.
Vice President, Legal
Mobile Phone
Email
Feb 11, 2026
C. M.
Vice President Of Clinical Operations
Mobile Phone
Email
UNITED STATES
Jun 21, 2024

Frequently Asked Questions

What is Inhibikase Therapeutics, Inc. known for?

Inhibikase Therapeutics, Inc. operates in the Pharmaceutical Manufacturing industry. The company's main headquarters is located in 1000 North West Street Suite 1200 Wilmington, Delaware United States. Explore Inhibikase Therapeutics, Inc.'s company overview page for more information.

What is Inhibikase Therapeutics, Inc.'s most common email format?

Inhibikase Therapeutics, Inc. employees' email format typically follows the pattern of . Trying to find reliable and up-to-date employee contact data? Find more Inhibikase Therapeutics, Inc. email formats with LeadIQ.

How many employees does Inhibikase Therapeutics, Inc. have currently?

Inhibikase Therapeutics, Inc. has approximately 27 employees as of March 2026. These team members are located across 3 continents, including North AmericaEuropeSouth America.

Who are Inhibikase Therapeutics, Inc.'s key employees and leadership?

As of March 2026, Inhibikase Therapeutics, Inc.'s key employees include:

Chief Human Resources Officer: J. J. K.
Chief Financial Officer: J. F.
Vice President Finance: K. W.
Vice President Of Clinical Operations: C. M.
President: R. A.

Looking for contact data? Unlock accurate emails and phone numbers for your ideal prospects with LeadIQ.

Everything for prospecting,
in one platform.

What you can expect from LeadIQ:

B2B data verified in real-time
Sync data to your CRM, & add it to an outreach sequence in one click
Integrations with your tech stack for optimal efficiency
A patented AI cold email generator
Account & contact-level job change tracking